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The PanX1 panel in the original version of [Fig. 6](#fig6){ref-type="fig"} A was a partial duplicate of the PanX1 panel in [Fig. 1](#fig1){ref-type="fig"}. The authors have indicated that this was due to a clerical error during figure preparation. The original version of [Fig. 1](#fig1){ref-type="fig"} and its legend also did not indicate that intervening lanes of the gel image had been removed for presentation purposes. Corrected versions of [Fig. 1](#fig1){ref-type="fig"} and [Fig. 6](#fig6){ref-type="fig"} A and their respective figure legends are shown below.

![Pannexin1 (PanX1) mRNA is ubiquitously expressed in prostate cell lines. A 2% agarose gel showing the expression of the PanX transcripts in human prostate cell lines LNCaP, PNT1A, DU-145, and PC-3, as well as in HEK-293 cells. A no-template control (H~2~O) was also run with the PCR samples, where the cDNA was replaced with water. White lines indicate the removal of intervening lanes for presentation purposes.](JCB_200601115R_Fig1){#fig1}

![(A) siRNA-PanX1 reduced the endogenous PanX1 mRNA expression in HEK-293 cells. Semiquantitative RT-PCR (PanX1, 36 cycles; β-actin, 27 cycles) showing a decrease in the expression of the PanX1 transcripts in HEK-293 cells transfected for 2 d with 100 nM of siRNA-PanX1. Note that this reduction was not observed when the cells were incubated with vehicle only. The β-actin mRNA expression was used to control the RNA rate in each sample.](JCB_200601115R_Fig6){#fig6}

The html and pdf versions of this article have been corrected. The errors remain only in the print version.
